Skip to content

Stock-Based Comp at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$300M+4.2%
Stryker logo
StrykerSYK
$87M+3.6%
Globus Medical logo
Globus MedicalGMED
$12.62M-4.5%
Alphatec Holdings logo
Alphatec HoldingsATEC
$23.66M+6.0%
Enovis logo
EnovisENOV
$8.75M+18.1%
OrthoPediatrics logo
OrthoPediatricsKIDS
$3.98M+3.2%

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Operating income-$14.4M+70.5%
Net income-$20.9M+60.6%
EPS (diluted)-$0.52+61.5%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%
Free cash flow-$28.3M-12.5%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s stock-based comp?
Orthofix Medical Inc. (OFIX) reported stock-based comp of $6.53M in Q1 2026.
How has Orthofix Medical Inc.'s stock-based comp changed year-over-year?
Orthofix Medical Inc.'s stock-based comp increased by 1.0% year-over-year, from $6.47M to $6.53M.
What is the long-term trend for Orthofix Medical Inc.'s stock-based comp?
Over 4 years (2021 to 2025), Orthofix Medical Inc.'s stock-based comp has grown at a 16.8% compound annual growth rate (CAGR), from $15.43M to $28.69M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.